Page 7 - Parse Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article FREMONT, Calif., Feb. 23, 2021 /PRNewswire/ -- The premium market intelligence report published by BIS Research on the title Global Single-Cell Multi-Omics Market highlights that the market is projected to reach $3.18 billion by 2025. The study also highlights that the market is set to witness a CAGR of 21.16% during the period between 2020 and 2025. The growth is aided by factors including increasing utilization of single-cell RNA sequencing for various cancer research. The single-cell multi-omics approach enables integrating different molecules and a...

Parse Biosciences Launches Whole Transcriptome Kit to Dramatically Scale Single Cell Sequencing Share Article Now commercially available, the Whole Transcriptome Kit enables researchers in neuroscience, immunology, oncology, as well as other areas of scientific study, to achieve industry-leading detail on cell types and subtypes “For too long, labs have been held back by technologies that not only compromise on data quality, but which also don’t scale to match researchers’ ambitions,” said Alex Rosenberg, co-founder and CEO of Parse. SEATTLE (PRWEB) ...

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single Cell RNA Sequencing Share Article As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Parse Biosciences In addition to increased scalability, Parse Biosciences’s technology also provides researchers with higher data quality. Parse enables researchers to increase gene detection in individual cells, while dramatically reducing confounding artifacts that a...